Rezultati - Anastasios Dimou, MD

Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report od Aditi Singh, MBBS, MPH, Arthi Sridhar, MBBS, Aastha Poddar, MBBS, Anastasios Dimou, MD, Kaushal Parikh, MBBS, Mohamed Shanshal, MD, Anna Schwecke, APRN, CNP, MS, Nicole Moffett, APRN, CNP, MSN, Manish R. Patel, DO, Aaron S. Mansfield, MD, Konstantinos Leventakos, MD, PhD

Polni tekst

Safety and Efficacy of Sequential Chemoimmunotherapy Followed by Concurrent Chemoradiation in Unresectable Stage III NSCLC od Arthi Sridhar, MD, Aditi Singh, MD, MPH, Scott Hansen, MD, Sydney Pulsipher, MD, Kaushal Parikh, MD, Aaron S. Mansfield, MD, Anastasios Dimou, MD, Julian R. Molina, MD, Katherine E. Smith, MD, Yolanda I. Garces, MD, Sean S. Park, MD, Aadel A. Chaudhuri, MD, PhD, Kenneth W. Merrell, MD, Kenneth R. Olivier, MD, Konstantinos Leventakos, MD, Dawn Owen, MD, PhD, Mohamed Shanshal, MD, MBBCh

Polni tekst